Harbor Advisory Corp’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-29,384
| Closed | -$2.38M | – | 86 |
|
|
2025
Q1 | $2.38M | Sell |
29,384
-721
| -2% | -$58.5K | 0.8% | 37 |
|
|
2024
Q4 | $2.71M | Sell |
30,105
-1,420
| -5% | -$128K | 0.89% | 37 |
|
|
2024
Q3 | $3.11M | Sell |
31,525
-145
| -0.5% | -$14.3K | 1.02% | 35 |
|
|
2024
Q2 | $2.94M | Sell |
31,670
-1,770
| -5% | -$164K | 1.01% | 34 |
|
|
2024
Q1 | $3.17M | Sell |
33,440
-75
| -0.2% | -$7.12K | 1.08% | 34 |
|
|
2023
Q4 | $2.99M | Sell |
33,515
-1,700
| -5% | -$152K | 1.07% | 34 |
|
|
2023
Q3 | $2.57M | Buy |
35,215
+25
| +0.1% | +$1.83K | 0.93% | 40 |
|
|
2023
Q2 | $2.93M | Buy |
35,190
+632
| +2% | +$52.6K | 1.03% | 37 |
|
|
2023
Q1 | $2.63M | Sell |
34,558
-100
| -0.3% | -$7.62K | 1.01% | 35 |
|
|
2022
Q4 | $2.88M | Buy |
34,658
+229
| +0.7% | +$19K | 1.18% | 35 |
|
|
2022
Q3 | $2.73M | Buy |
34,429
+1,218
| +4% | +$96.6K | 1.26% | 33 |
|
|
2022
Q2 | $2.47M | Buy |
33,211
+18,302
| +123% | +$1.36M | 1.08% | 35 |
|
|
2022
Q1 | $1.34M | Buy |
14,909
+496
| +3% | +$44.6K | 0.54% | 48 |
|
|
2021
Q4 | $1.61M | Sell |
14,413
-3,288
| -19% | -$368K | 0.65% | 42 |
|
|
2021
Q3 | $2.23M | Buy |
17,701
+11,986
| +210% | +$1.51M | 0.97% | 36 |
|
|
2021
Q2 | $774K | Buy |
+5,715
| New | +$774K | 0.35% | 52 |
|